Kitzen, J M <br/><br/>
Potassium channel activators cromakalim and celikalim (WAY-120,491) fail to decrease myocardial infarct size in the anesthetized canine.  [electronic resource] 

 -  Pharmacology  1992 
 - 71-82 p.  digital 
<br/><br/> Publication Type: Journal Article 
<br/><br/><label>ISSN: </label>0031-7012 
<br/><br/><label>Standard No.: </label>10.1159/000138982  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Animals<br/>Benzopyrans--pharmacology<br/>Coronary Circulation--drug effects<br/>Coronary Vessels--physiopathology<br/>Cromakalim<br/>Disease Models, Animal<br/>Dogs<br/>Hemodynamics--drug effects<br/>Indoles--pharmacology<br/>Myocardial Infarction--pathology<br/>Perfusion<br/>Potassium Channels--drug effects<br/>Pyrroles--pharmacology<br/>Regional Blood Flow--drug effects